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Introduction
The prevalence of severe and complex obesity is worsening in most parts of the world (1) . One effective treatment is bariatric surgery (BS), and this is a rapidly growing area (2) . Evaluating surgery including assessment of patients' views is important (3) . Quality of Life (QoL) is a key outcome that should be reported in all clinical effectiveness trials in BS (4, 5) . Indeed, a recently developed Core Outcome Set (COS) for BS identified QOL as one of the nine items included in the final COS and therefore assessed in clinical trials in this area (4) . The World Health Organization defined QoL as an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. QoL data offer a reliable assessment of the patients' perspectives of BS outcomes and can be useful in decision-making.
Bariatric surgery generates significant improvements in some aspects of QoL, particularly in physical domains (6) . The substantial weight loss following BS, however, leaves many patients with other issues, such as excess skin, which can have a negative impact on other domains of QoL (e.g. body image, physical and sexual functioning). Subsequent body contouring surgery (BCS) has considerable potential to restore QoL (7) (8) (9) . Therefore, the growth of BS has been paralleled with increasing numbers of post-bariatric body contouring procedures (10) . Patient-reported outcome (PRO) measurement of QoL is highly desirable in postbariatric BCS but is not yet routinely captured in (post-)bariatric outcome measurement. Given the growing field of BCS, the need to understand QoL and cosmetic issues related to surgical outcomes over the entire weight loss journey is important and requires information about the most appropriate PRO measurement instrument for this purpose.
A limitation in the pursuit of such evidence is the lack of standardization of the measurement of QoL and instruments available to assess it. The wide variety of generic and disease-specific questionnaires has made meta-analyses and interpretation across studies difficult (11) (12) (13) (14) . This makes it difficult to decide what treatments are best as perceived by the patient and, hence, hampers evidence-based clinical decision making. To address the lack of standardized PRO measurement instruments (PROMs) in both bariatric and post-bariatric BCS, recommendations about the most appropriate measurement instrument(s) of QoL should be made based on quality standards and criteria. In this systematic review, we aim to provide validation evidence about the most appropriate PROMs of QoL in bariatric and post-bariatric BCS. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology was used as guidance to assess and provide recommendations on the most appropriate measurement instrument(s) (15) . This review is a continuation of a project to develop a COS for bariatric and metabolic surgery clinical trials (4) .
Material and methods
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement was used as a guidance for reporting this systematic review (16) . This review has been registered in the International Prospective Register of Systematic Reviews: CRD42017059783.
Eligibility criteria
Studies were selected if published as full-text papers and if their purpose was the development ('development paper') and/or evaluation ('validation paper') of the measurement properties of instruments that measure QoL in BS and/or BCS patients. Studies that reported indirect evidence, such as clinical trials measuring QoL, were not considered eligible. Eligible instruments included all PROMs that are specifically designed and/or validated to measure QoL in BS and/or BCS patients. Articles were excluded if (i) a different construct than QoL was measured, (ii) PROMs were developed for children or adolescents (age < 18 years) that underwent BS, and (iii) PROMs were solely developed to measure the QoL of patients with obesity not related to BS or BCS.
Literature search
On 25 January 2017, we conducted a systematic literature search in PubMed, EMBASE, Ebsco/PsycINFO, Ebsco/CINAHL, Cochrane Database Systematic Reviews and CENTRAL identifying studies on measurement properties of PROMs of QoL or Health-Related Quality of Life (HRQoL) in BS and BCS patients. We interpreted QoL and HRQoL interchangeably. We involved a clinical librarian to optimize the search strategy. The main search strategy consisted of four blocks of search terms: (i) target population (BS and BCS patients); (ii) construct of interest (QoL); (iii) type of instrument; and (iv) measurement properties. The search filter Patient Reported Outcomes Measures (PROMs), developed by Oxford University and available through the COSMIN website (www.cosmin.nl) and a highly sensitive search filter for finding studies on properties of measurement instruments (17) , were used for these purposes. We did not limit our search to year of publication, study design or language. The entire search can be found in Data S1. The search results were handled within Reference Manager. The reference lists of included studies were hand searched for additional articles. We searched the Patient-Reported Outcome and Quality of Life Instruments Database database (http://www.proqolid.org) for additional information.
Study selection and data extraction
Two reviewers (C. V. and M. K.) independently screened titles and abstracts and, at a second stage, assessed the fulltext articles retrieved by the literature search to identify studies evaluating measurement properties. Conflicts were resolved by consensus of the two reviewers and, if necessary, a third reviewer (C. P.). For all eligible studies, the same two independent reviewers (C. V. and M. K.) extracted data from the selected studies. Data extracted included the characteristics of included studies and instruments, and results on measurement properties. Evidence tables were used to summarize data.
Evaluation of the methodological quality of studies on measurement properties
The COSMIN study developed a consensus-based checklist to evaluate the methodological quality of studies on measurement properties (15) . The COSMIN checklist describes standards for design requirements and preferred statistical methods. We evaluated the methodological quality of studies on their measurement properties using the COSMIN checklist. The COSMIN taxonomy was used to select which measurement properties of an instrument were evaluated (18) . According to the COSMIN taxonomy, three domains can be distinguished: reliability, validity and responsiveness (18) . The measurement properties internal consistency, reliability and measurement error fall within the domain validity, the measurement properties content validity, construct validity and criterion validity fall within the domain validity and the measurement property responsiveness falls within the domain responsiveness. We assessed internal consistency, reliability, measurement error, content validity (including face validity), structural validity, hypotheses testing (i.e. for convergent and divergent validity) and crosscultural validity (these three are aspects of construct validity), criterion validity and responsiveness. As, in general, there is no gold standard for PROMs, 'criterion validity' was not considered. Each measurement property can be rated as excellent, good, fair or poor (19) . The 'lowest score counts' principle was used, which means that the overall rating for the study was determined by the lowest rated measurement property.
The same two reviewers (C. V. and M. K.) independently evaluated the methodological quality of included studies. Discrepancies were discussed with a third reviewer (C. P.) to reach consensus. For the measurement property 'hypothesis testing', we evaluated convergent/divergent validity and discriminative validity. Convergent/divergent validity is the correlation between a comparator instrument that measures a similar or different construct. Discriminative validity is the ability of a measurement instrument to make a distinction between different subgroups. Data on the interpretability and generalizability were collected when data were available. Interpretability and generalizability do not refer to the quality of an instrument and are therefore not measurement properties. These characteristics are included in the COSMIN checklist, as they provide important information on the suitability of a measurement instrument. Interpretability describes whether it is clear what the scores or change scores of the instrument of interest mean. Interpretability includes an assessment of the distribution of scores, floor and ceiling effects (the percentage of patients with the lowest or highest scores; e.g. a high percentage of patients with the highest scores [ceiling effect] limits the ability to measure changes) and minimal clinically important difference (the smallest difference in construct [QoL scores] between patients that is considered clinically important). Generalizability describes whether the patient population in which the measurement instrument was evaluated was adequately described to generalize the results. We evaluated different language versions of QoL measurement instruments as distinct instruments. We assumed that different language versions possess different measurement properties.
Quality of the measurement properties
We independently evaluated the quality of the measurement properties of the included measurement instruments by applying the Terwee criteria for good measurement properties (20) on which international consensus was obtained (21) ( Table 1 ) (22) . The quality of each measurement property was rated as positive (+), negative (À) or indeterminate (?).
Quality of the instruments: best evidence synthesis
Taking both the quality of the studies and the quality of the measurement instruments into account, the overall evidence on a measurement property includes the number and the methodological quality of the included studies and the consistency of their results. The overall rating of the quality of a measurement property was based on a levels of evidence approach (23) . The results of studies of poor methodological quality were not included in the best evidence synthesis. The criteria of best evidence synthesis are shown in Table 2 .
Recommendations for the selection of the most suitable Quality of Life measurement instruments
Recommendations on the most suitable QoL instruments were based on the methodological quality of included studies and on the adequacy of the instrument. As previously described by the Harmonizing Outcome Measures for Eczema initiative, the three criteria of the Outcome Measures in Rheumatology filter had to be met by a measurement instrument to be recommended for use. Outcome measures should adequately meet the criteria of (i) truth (i.e. face, content, construct and criterion validity; measure what it is intended to measure), (ii) discrimination (i.e. reliability and sensitivity to change; discriminate between situations of interest) and (iii) feasibility (i.e. be applied and interpreted easily) in order to be meaningful and relevant (24) . Four degrees of recommendation were assigned to validated instruments included in this review (A-D), adopted from the Harmonizing Outcome Measures for Eczema initiative and applied in previous reviews of this initiative (25): A. QoL measurement instrument meets all requirements and is recommended for use. B. QoL measurement instrument meets two or more quality criteria, but performance in all other required quality criteria is unclear, so that the PRO measurement instrument has the potential to be recommended in the future depending on the results of further validation studies. C. QoL measurement instrument has low quality in at least one required quality criterion (≥1 rating of 'minus') and therefore is not recommended for usage. D. QoL measurement instrument has (almost) not been validated. Its performance in all or most relevant quality criteria is unclear, so it is not recommended to be used until further validation studies clarify its quality.
Results
Out of the 4,354 articles, 26 articles described development and validation of a measurement instrument and were considered eligible for assessment of the methodological quality (Data S2). These described 24 measurement instruments in 26 studies. Of the measurement instruments included, 21 were developed for BS patients, two for both BS and BCS patients and one for BCS patients. The characteristics of the different instruments are displayed in Table 3 . Important characteristics of the included development and validation studies are shown in Table 4 . Information on the content (i.e. on domain level) of the different instruments is shown in Table 5 . Social functioning was captured in all measurement instruments except the EQ-5D-5L, physical functioning was included in all instruments except the bariatric and obesity-specific survey and sexual functioning was included in all instruments except the Bariatric Quality of Life Index (BQL-Index), the Quality of Life for Obesity Surgery, the EQ-5D-5L and the Gastrointestinal Quality of Life Index (GIQLI). Data S3 shows the detailed results of interpretability of the QoL measurement instruments. Values for the minimal clinically important difference were only available for the Laval Questionnaire and the EQ-5D-5L. The BQL-Index, the BODY-Q, the Spanish Obesity-related Problems scale (OP-scale), the Greek Moorehead-Ardelt Quality of Life Questionnaire II (M-A QoLQII) and the Portugese M-A QoLQII showed no evidence for floor or ceiling effects. The EQ-5D-5L demonstrated ceiling effects and the Danish BODY-Q demonstrated ceiling effects in the experience scales.
Quality assessment and results of the studies
The methodological quality of the included studies is presented in Table 6 , and the quality assessment of the measurement properties is presented in Table 7 . Data S4 describes detailed results of the different measurement properties of every single instrument and study.
Quality of the instruments: best evidence synthesis
The results of the best evidence synthesis and recommendations of QoL instruments (Table 8) are described in the succeeding texts according to the category of recommendation (A-D) ( Table 9 ):
Category A instruments
No instrument met all required quality criteria to be recommended for the measurement of QoL in BS and/or BCS.
Category B instruments
Seven measurement instruments have the potential to be recommended for BS and/or BCS in the future depending on further validation studies.
Body-Shape-Related Quality of Life (body contouring surgery).
The measurement properties of the Body-ShapeRelated Quality of Life were evaluated in two studies. Strong evidence was found for good content validity (27) , moderate evidence for good internal consistency, limited evidence for good reliability and moderate evidence for indeterminate structural validity and hypotheses testing (26) . The evidence for responsiveness remained unclear due to poor methodological quality of the study (26) . For interpretability, the mean absolute change in score from baseline was 21.9 (SD 16.9) (26). 
Bariatric and obesity-specific survey (bariatric surgery). The measurement properties of the bariatric
and obesity-specific survey were evaluated in one study. Moderate evidence was found for good internal consistency and reliability (32) . There was moderate evidence for indeterminate content validity and structural validity (32) . The evidence of hypotheses testing remains unknown because of poor methodological quality of the study (32) .
Quality of Life for Obesity Surgery (bariatric surgery). The measurement properties of the Quality of
Life for Obesity Surgery were evaluated in one study. There was strong evidence for good content validity, moderate evidence for good internal consistency and structural validity and limited evidence for indeterminate hypotheses testing (41) .
Norwegian Obesity-related Problems scale (bariatric surgery). The measurement properties of the Norwegian
OP-scale were evaluated in one study. Moderate evidence was found for good internal consistency and structural validity, and limited evidence was found for good hypotheses testing and responsiveness (45) . The evidence for cross-cultural validity remains unknown because of poor methodological quality of the study (45) . Interpretability yielded a mean absolute change of 42.29 (45) .
Spanish Obesity-related Problems scale (bariatric surgery). The measurement properties of the Spanish
OP-scale were evaluated in one study. Moderate evidence was found for good internal consistency and structural validity, and limited evidence was found for good hypotheses testing (47) . The evidence for cross-cultural validity remains unknown because of poor methodological quality of the study (47) .
Danish BODY-Q (bariatric surgery and body contouring surgery).
Two studies evaluated the measurement properties of the Danish BODY-Q. There was strong evidence for good content validity, moderate evidence for good cross-cultural validity and limited evidence for good internal consistency and structural validity (43, 44) .
Category C instruments
Two instruments (BS) had poor quality in at least one required quality criterion and were not recommended to be used in BS (category C). The BQL-Index (34, 35) and the Laval Questionnaire (33) had low quality in one measurement property. Structural validity was poor for the BQL-Index (34), and conflicting evidence was found for responsiveness of the Laval Questionnaire (33) . and Spanish IWQoL-lite (46) . The evidence of the majority of the measurement properties of these instruments could not be interpreted due to poor methodological quality of the study. The OP-scale showed moderate evidence for good internal consistency and structural validity (40) , and the Spanish IWQoL-lite showed moderate evidence for good internal consistency and limited evidence for good structural validity (46) . Limited evidence was found for good reliability of the Greek and Portuguese M-A QoLQII (48,50). Conflicting evidence was found for hypotheses testing of the EQ-5D-5L (42) .
Category D instruments

Discussion
This systematic review evaluated and compared the measurement properties of 21 QoL instruments designed for use in BS, one QoL instrument designed for use in BCS and two QoL instruments designed for use in both BS and BCS. None of these instruments complied with the filter requirements of truth, discrimination and feasibility, which obesity reviews indicates the need for further validation studies. Hence, no QoL instrument can currently be highly recommended. All identified instruments have gaps in their validation, and none of the instruments provided evidence of the quality of measurement error or estimated a minimally important difference. Remarkably, criterion validity was still described as a measurement property in some validation studies, even though no true gold standard is available in QoL measures. Further work is needed to validate the available tools for BS and BCS, and this should be a priority.
The most frequently used instruments in BS, such as the M-A QoLQ (Bariatric Analysis and Reporting Outcome System), the GIQLI, M-A QoLQII, EQ-5D and the IWQoL-Lite, lack adequate and methodologically good validation data (12, 52) . Their methodological quality was mostly poor across all measurement properties. The GIQLI lacks domains relevant to BS and BCS in particular. Adequate validation studies are needed to clarify the quality of these instruments before they can be recommended for use in clinical trials and prospective studies. Of the QoL instruments placed in category B, this review suggests that the BODY-Q has the most potential to be recommended in the future depending on the results of further validation studies. The BODY-Q intended for use in both BS and BCS was supported by positive evidence of internal consistency, reliability and adequate structural validity. Compared with the other instruments, the BODY-Q is unique in the application of a modern psychometric approach, Rasch Measurement Theory (RMT) analysis, in the development of the measurement instruments. RMT analysis provides more sophisticated information than the traditional approach, the classical test theory, and offers a major contribution to the concept of reliability. In the classical test theory approach, scale (IWQOL-Lite) or item (M-A QoLQ) scores can be added to create a total score for a measurement instrument. There is no evidence, however, that the summed total scores allow for meaningful interpretation of scores (53, 54) . This approach limits its information to identify whether or not treatment effects are influenced by some scales or items and not others (53, 54) . Most importantly, the BODY-Q showed excellent content validity, as the development of the items of the BODY-Q was based on a literature review, patient interviews, cognitive patient interviews and input from experts. The BODY-Q is useful for the target population (BS and BCS), particularly with the growing field of BCS in mind. A disadvantage of the BODY-Q is that not many translations are already available and the long completion time of 138 items. Nevertheless, the RMT approach provides the opportunity for Computer Adaptive Testing, which can reduce the length of the measurement instrument. Further validation studies of the BODY-Q should focus on measurement error, construct validity and interpretability. This is the first systematic review to make recommendations based on quality standards and criteria; previous systematic reviews reported only on measurement properties (11) (12) (13) (14) . The COSMIN checklist, the levels of evidence and the four degrees of recommendations were used as quality standards and criteria. We applied two sensitive and validated search filters and used predefined eligibility criteria to identify all PROMs in BS and BCS. In the present study, we were as inclusive as possible to give a comprehensive overview of all PROMs in BS and BCS (e.g. we included the IWQoL-Lite in our review, even though the measurement properties were only described in a systematic review). On the other hand, we were strict in excluding PROMs validated solely in patients with obesity -not BS or BCS -such as the Obesity and Weight-Loss Quality of Life and the Weight-Related Symptoms measures. We gathered information on interpretability and generalizability. At least two reviewers performed all steps in our systematic review with frequent discussions to resolve conflicts.
We have used the COSMIN checklist, published in 2010, to evaluate the methodological quality of the studies. Some of the PROMs may be of higher quality than indicated by the COSMIN checklist simply because the studies were performed longer ago and measurement properties were not reported. Almost all instruments developed after publication of the COSMIN checklist performed best, which could be due to more strict standards on how to perform studies on measurement properties. Only the Post Bariatric Outcome 
